5α-Hydroxy-laxogenin
Chemistry
- Formula
- C27H42O5
- Molar mass
- 446.6 g/mol
- IUPAC name
- (1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S,18R)-16,18-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one
- InChIKey
- HCRGPOQBVFMZFY-PPCFKNSFSA-N
Chemistry from PubChem CID 69906537.
Also known as
- 25R,5alpha-Spirostan-3beta,5-diol-6-one
- RefChem:483956
- 884-776-3
- 56786-63-1
- 5-alpha-Hydroxy-laxogenin
- 5alpha-Hydroxy laxogenin
- Biobras 16
- Spirostan-6-one, 3,5-dihydroxy-, (3b,5a,25R)-
Stereoisomers
8 distinct stereoisomers are registered for this structure.
- 25R,5alpha-Spirostan-3beta,5-diol-6-one this area CID 69906537
- (1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16R,18S)-16,18-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one CID 11496038
- (1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S,18S)-16,18-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one CID 11510611
- (1S,2R,4S,5'R,6R,7S,8S,9S,12S,13R,16S,18R)-16,18-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one CID 124225366
- (1S,2R,4S,5'R,6S,7S,8S,9S,12R,13R,16S,18R)-16,18-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one CID 124225367
- (1S,2R,4S,5'R,6R,7S,8S,9S,12R,13R,16S,18R)-16,18-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one CID 124225368
- (1S,2R,4S,5'R,6S,7S,8S,9S,12S,13R,16S,18R)-16,18-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one CID 124225369
- (1S,2S,4R,5'R,6R,7S,8R,9S,12R,13R,16S,18R)-16,18-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one CID 131632446
- 16,18-Dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one mixture CID 3845107
Named in dossiers
- Umbrella Labs sells our grade 39/100
General Open discussion — anything that fits nowhere narrower. no posts yet Legal Scheduling status, pending actions, and where the law actually stands. no posts yet Dosage Dose ranges by route, and the margins between them. no posts yet Experiences First-hand reports — set, setting, and what actually happened. no posts yet Chemistry Structure, synthesis, and analytical chemistry. no posts yet Interactions Combination risks — what must not be mixed, and why. no posts yet
No posts here yet.